Lantheus Holdings: the Next Big Winner in Alzheimer’s Diagnostics?
Reading Time: 4 minutes
• Billion-dollar market with growth potential: The number of Alzheimer’s cases is rising rapidly, and the diagnostics market could explode in growth over the next few years. • Technological leadership & expansion: Lantheus focuses on early diagnosis with innovative radiopharmaceuticals and strengthens its market position through strategic acquisitions. The healthcare sector is on the verge of a breakthrough in Alzheimer’s diagnostics, and Lantheus Holdings (NASDAQ: LNTH) could be one of the biggest beneficiaries. While the company...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
